HPMC K15M

The aim of the present work was to design controlled release tablet of Tramadol hydrochloride for prolong release and it’s in vitro evaluation. Controlled tablets of Tramadol hydrochloride comprised HPMC K15M, and HPMC K100M as the release retarding polymers. These tablets were prepared by direct compression method. The seven different formulations (F1-F7) were evaluated for pre- and post-compression parameters. In vitro dissolution studies were carried out for the optimized formulation (F7). It has found that the release of drug from the sustained release layer by 99.5% in 12 h. FT-IR studies revealed that there was no interaction between the drug and polymers used in the study. The release of Tramadol hydrochloride was found to follow a pattern of Korsmeyer-Peppas, with Quasi-Fickian diffusion. Accelerated stability studies were carried out on the prepared tablets in accordance with ICH guidelines. There were no changes observed in physicochemical properties and drug release pattern of tablets. The controlled drug release pattern was successfully achieved through the formulation of controlled tablets in this study.

Cefadroxil is a first generation cephalosporin antibiotic intended for oral administration. In the Present investigation, an attempt has been made to increase the therapeutic efficacy to reduce the frequency of administration and to improve the patient compliance by developing the sustained release matrix tablets of Cefadroxil by using direct compression method. Excipients like Xanthun gum, HPMC K 15 M, PVP K 30 are used as matrix polymers. MCC used as diluents, magnesium stearate as lubricant, and talc act as a glidant. The different excipients were tested for their compatibility with the drug Cefadroxil by using FTIR and DSC, which revealed that there was no chemical and physical interaction occurred. Then the Preformulation parameters like bulk density, tapped density, compressibility index, and Hauser’s ratio were analyzed for prepared powder before compression. The thickness of best formulation CF9 is 3.5mm, hardness of best formulation CF9 is 3.6kg/cm2, friability of best formulation CF9 is 0.66%, weight variation of best formulation CF9 is 499±0.39.The In-vitro drug release were performed in the USP Apparatus (basket) using 0.1 N HCL as dissolution media at 50 rpm speed. The sample was done at periodic intervals of 1hr, 2hr, 3hr, 4hr, 5hr, and 6hrs and was replaced with equal volume of dissolution media to maintain the sink condition. The best In-vitro release shown by formula CF9 that is 95% .The results indicate that the selected formulation was stable during the period of accelerated stability studies. The optimized formulation CF9 compared with the marketed sample Cetil-500mg. Marketed sample in-vitro drug release is 98.85%. All evaluated formulations results were found to be satisfied.

The purpose of present work was for formulation and characterization of Clopidrogrel floating tablets to improve bioavailability and to minimize the side effects of the drug. FTIR studies were conducted for drug polymer compatibility. The Clopidrogrel sustained release floating tablets were formulated by wet granulation method.  Tablets were subjected to pre and post compressional evaluation studies. The different concentrations of HPMC K4M, HPMC K15M, xanthan gum, guargum, and sodium bi carbonate 25% w/w is used as gas generating agent and micro cellulose crystalline MCC are used in different concentrations (75%, 50%, 25%) as diluent. The tablets were tested for thickness, weight variation, hardness, friability, drug content; In vitro floating parameters and drug release studies were also conducted. Compatibility studies revealed that there is no interaction between drug and polymers in the formulations. The flow properties were within the limits and the granular bed exhibited uniform flow and ease for compression. Clopidogrel floating tablets showed uniform post compressional properties with minimum standard deviation. The formulations showed minimum floating lag time and prolonged duration of floating. In vitro drug release of clopidogrel was sustained up to 12 h. Clopidrogrel release followed zero order, first order, Higuchi drug release kinetics for drug release. The peppas diffusion coefficient ranged from 0.455 - 0.895 indicating drug release by non fickian diffusion followed by erosion. The F4 floating tablet was optimized formulation which showed 100% release sustained for 12 h. The stability studies indicated stability of drug in the optimized formulation against temperature and humidity.

A controlled release system is designed to provide constant or nearly constant drug levels in plasma with reduced dose, frequency of administration and fluctuations in plasma concentrations via slow release over an extended period of time.One of the least complicated approaches to the manufacture of controlled release dosage forms involves the direct compression of blend of drug, retardant material and additives to formulate a tablet in which the drug is embedded in a matrix of the retardant. Gabapentin is an anti epileptic drug used for the treatment of epileptic seizures and in treatment of post therapeutic neuralgia.  In this study controlled released Gabapentin matrix tablets were prepared by using different matrix forming polymers which include hydrophilic polymers like HPMC K15M, HPMC K100M, Xanthan gum and hydrophobic polymer like Ethylcellulose in various ratios to retard the release of drug upto 12hrs. The formulations containing the combination of hydrophilic and hydrophobic polymer combinations (HPMC K100M with Ethycellulose) and the formulations prepared with the combination of two hydrophilic polymers of synthetic and natural origin (HPMC K100M with Xanthan Gum) exhibited maximum drug release(99%) upto12hrs during in vitro dissolution studies with optimum swelling characteristics.